NEW CP101 Molecular Microbiology in the Community-Based Practice
9:30–11:30 am
2.0 CME CREDITS
Recent technological advances are making on-site molecular testing for infectious diseases an achievable goal for an increasing number of community-based laboratories. Concurrently, changes in diagnostic algorithms and advances in therapies are affecting the utilization and interpretation of commonly encountered, specialized molecular microbiology tests. In this discussion of current assays, practicing pathologists and trainees will gain the skills to evaluate molecular tests for incorporation into the community-based clinical laboratory. Faculty will focus on understanding current molecular technologies and evaluating clinical utility. In addition, they will explore recent advances in diagnosis and treatment of specific infections, including HIV and HCV, with special emphasis on the implications for molecular test utilization and interpretation.
You will learn to:
- Evaluate new molecular infectious disease assays to determine suitability for incorporation into the community-based laboratory
- Incorporate knowledge of recent clinical advances in the selection, utilization, and interpretation of molecular infectious disease tests
- Identify resources that help facilitate the implementation and continued utilization of molecular testing in the clinical laboratory
Faculty
Cindy B. McCloskey, MD, FCAP